AFT gets first step of US approval for Maxigesic IV

AFT gets first step of US approval for Maxigesic IV
Sophie Boot
By Sophie Boot March 24 (BusinessDesk) - AFT Pharmaceuticals has crossed the first hurdle in getting the intravenous version of its patented combination painkiller Maxigesic approved by the US Food and Drug Administration. The investigational new drug application (IND) for Maxigesic IV has been approved by the FDA, which is the first step towards getting approval in the US, the Auckland-based drugmaker said in a statement. It will now conduct a clinical study in Christchurch, followed by one in the US, as part of the path to gaining appro...